Michael Cartwright to Recombinant Fusion Proteins
This is a "connection" page, showing publications Michael Cartwright has written about Recombinant Fusion Proteins.
Connection Strength
0.963
-
Oechsel KF, Cartwright MS. Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1. Muscle Nerve. 2021 Oct; 64(4):487-490.
Score: 0.771
-
Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
Score: 0.192